 |
Recombinant secretory leucocyte protease inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-29 00:00:00 |
| Sponsor | Amgen, Inc.;3200 Walnut Street;Boulder, Colorado, 80301 |
Related Access Program
| |
Recombinant secretory leucocyte protease inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-29 00:00:00 |
| Sponsor | Amgen, Inc.;3200 Walnut Street;Boulder, Colorado, 80301 |